Home
Scholarly Works
Tocilizumab versus the Covid19 tempest: All’s well...
Journal article

Tocilizumab versus the Covid19 tempest: All’s well that ends well or much ado about nothing?

Authors

Lee TC; Butler-Laporte G; Chagla Z; McDonald EG

Journal

Clinical Microbiology and Infection, Vol. 27, No. 2, pp. 158–159

Publisher

Elsevier

Publication Date

February 1, 2021

DOI

10.1016/j.cmi.2020.09.033

ISSN

1198-743X

Contact the Experts team